Treatment of hypoglycemia contributes to ASCVD risk reduction.

A person cannot be denied health care coverage and benefits because they have diabetes prior to employment.

T1D patients with certain characteristics would benefit the most from reimbursement of blood glucose test strips.

David Kliff from Diabetes Investor adds his thoughts about what is happening in the diabetes marketplace.

At her last visit, your patient’s labs showed a eGFR 55 ml/min/1.73 m2. At this visit, her labs measured an eGFR of 44 ml/min/1.73 m2. Dose reduction/cessation should be considered for all of the following agents EXCEPT: A. Glyburide B. Sitaglipitin C. Metformin D. Pioglitazone Follow the link for the correct answer.

What percentage of your prediabetes patients do you recommend a pharmaceutical treatment? 1. 10-25% 2. 25-50% 3. Greater than 50% 4. Zero. I only recommend diet and exercise. Follow the link to share your response.

In part 2 of this Exclusive Interview, Dr. Leigh Perreault talks with Diabetes in Control Medical Editor Joy Pape during the ADA meeting in San Diego, California, about the surprising sources of calories in most people's diets.

I have had several patients who did well at first with their GLP-1 agonists. Patient 1: Man, 46 years of age, used liraglutide 3mg daily for obesity. Patients 2 & 3: 2 women in their 60s were using liraglutide for type 2 diabetes & weight.

In this week's Homerun Slides, the summary of the role of plasma protein (S1P) in glycocalyx protection.

Any discussion of lipid and lipoprotein metabolism in diabetes mellitus, especially type 2 diabetes mellitus (T2DM), must consider the role of insulin resistance (IR). IR plays a central role in the abnormal lipid and lipoprotein metabolism of T2DM [1] as evidenced by the characteristic set of lipid and lipoprotein abnormalities accompanying IR, even in the absence of frank hyperglycemia or abnormal glucose tolerance. Individuals with IR have low plasma levels of HDL-C and elevations in plasma triglyceride (TG) levels compared with levels seen in individuals who have normal insulin sensitivity. There is also an increase in the proportion of low-density lipoprotein (LDL) particles that are small, dense, and cholesterol ester-poor. I